Charles River Labs Intl Stock
Charles River Labs Intl Stock
Charles River Labs Intl gained 0.760% compared to yesterday.
Charles River Labs Intl is currently one of the favorites of our community with 19 Buy predictions and no Sell predictions.
On the other hand, the target price of 165 € is below the current price of 165.7 € for Charles River Labs Intl, so the potential is actually -0.42%.
Pros and Cons of Charles River Labs Intl in the next few years
Pros
?
G***** c******* t* c**********
?
B****
?
M***** P*******
Cons
?
S********** s********
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Charles River Labs Intl vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Charles River Labs Intl | 0.760% | 3.918% | 13.063% | -9.394% | -6.959% | -16.650% | -16.944% |
| Ironwood Pharmaceuticals | -1.960% | 4.795% | 12.500% | -7.273% | -27.143% | -73.689% | -69.091% |
| Novocure Ltd | -1.150% | 9.135% | 16.554% | -64.364% | -61.023% | -84.072% | -91.840% |
| Iovance Biotherapeutics Inc. | 3.560% | -0.393% | -12.191% | -74.842% | -72.809% | -71.057% | -95.462% |
Comments
Charles River Laboratories International (NYSE:CRL) was upgraded by analysts at Argus from a "hold" rating to a "buy" rating.
Show more
Ratings data for CRL provided by MarketBeat
Charles River Laboratories International (NYSE:CRL) had its price target lowered by analysts at TD Cowen from $205.00 to $197.00. They now have a "buy" rating on the stock.
Show more
Ratings data for CRL provided by MarketBeat
Charles River Laboratories International (NYSE:CRL) had its price target raised by analysts at Barclays PLC from $195.00 to $210.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for CRL provided by MarketBeat
News
Charles River Laboratories Schedules Second-Quarter 2025 Earnings Release and Conference Call
Charles River Laboratories International, Inc. (NYSE: CRL) will release second-quarter 2025 financial results on Wednesday, August 6th, before the market opens. A conference call has been scheduled
Charles River Announces Endosafe® Cartridge Recycling Program, Strengthening Sustainability Commitment
Charles River Laboratories International, Inc. (NYSE: CRL) today announced a recycling program, developed in partnership with international recycling leader TerraCycle®, to give new life to